{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:38:23Z","timestamp":1791049103316,"version":"4.1.0"},"reference-count":67,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Myasthenia gravis (MG) is a rare autoimmune neuromuscular disease characterized by fluctuating muscle weakness and a variable clinical course. While sex differences in MG onset and progression are well documented, the extent to which these disparities affect quality of life (QoL)\u2014particularly through fatigue and psychological burden\u2014remains unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To systematically evaluate gender differences in QoL among MG patients and assess whether psychological factors and fatigue contribute to these disparities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were conducted in accordance with Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources and methods:<\/jats:title>\n                    <jats:p>Searches were performed in PubMed, Embase, and PsycINFO from inception through February 2025. Eligible studies included adult MG patients with QoL outcomes stratified by gender. QoL scores were synthesized using a random-effects model. Psychological and fatigue-related variables were examined qualitatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twelve studies (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u20094744; 2889 women, 1855 men) met the criteria for the systematic review, and five studies (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u20093765) were included in the meta-analysis. Women consistently reported lower QoL compared to men. The initial pooled analysis showed a moderate but non-significant effect (Hedges\u2019\n                      <jats:italic toggle=\"yes\">g<\/jats:italic>\n                      \u2009=\u20090.319,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.0812;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      \u00b2\u2009=\u200994.96%). Sensitivity analysis (excluding an outlier study) reduced heterogeneity (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      \u00b2\u2009=\u20090%) and revealed a significant gender effect (Hedges\u2019\n                      <jats:italic toggle=\"yes\">g<\/jats:italic>\n                      \u2009=\u20090.440,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001), with women experiencing significantly poorer QoL. Psychological comorbidities\u2014particularly depression and anxiety\u2014and higher levels of fatigue were more prevalent among female patients and consistently associated with lower QoL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Women with MG experience significantly reduced QoL, partially attributable to higher fatigue and psychological burden. These findings underscore the need for gender-sensitive approaches in MG management, including routine psychological screening and fatigue interventions. Future research should adopt standardized assessment tools and explore the impact of hormonal life stages on MG outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>PROSPERO CRD420251011446.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562864251344742","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T12:10:41Z","timestamp":1752495041000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Female gender and quality of life outcomes in myasthenia gravis: a systematic review and meta-analysis"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2617-5453","authenticated-orcid":false,"given":"Francesca","family":"Beeching","sequence":"first","affiliation":[{"name":"Non-Invasive Brain Stimulation Research Unit, Institute of Clinical Neuroscience of Southern Switzerland, Regional Hospital of Lugan-Civic (EOC), Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0309-6714","authenticated-orcid":false,"given":"Alessandro","family":"Lecchi","sequence":"additional","affiliation":[{"name":"Non-Invasive Brain Stimulation Research Unit, Institute of Clinical Neuroscience of Southern Switzerland, Regional Hospital of Lugan-Civic (EOC), Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1202-5534","authenticated-orcid":false,"given":"Gianna Carla","family":"Riccitelli","sequence":"additional","affiliation":[{"name":"Non-Invasive Brain Stimulation Research Unit, Institute of Clinical Neuroscience of Southern Switzerland, Regional Hospital of Lugan-Civic (EOC), Via Tesserete 46, Lugano 6900, Switzerland"},{"name":"Faculty of Biomedical Sciences, University of Southern Switzerland, Lugano 6900, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30411-9"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt9243"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/eva.13167"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01604-z"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2009.04.005"},{"issue":"7","key":"e_1_3_4_8_2","article-title":"Characterizing myasthenia gravis symptoms, exacerbations, and crises from neurologist\u2019s clinical notes using natural language processing","volume":"16","author":"Darer JD","year":"2024","unstructured":"Darer JD, Pesa J, Choudhry Z, et al. Characterizing myasthenia gravis symptoms, exacerbations, and crises from neurologist\u2019s clinical notes using natural language processing. Cureus 2024; 16(7): e65792.","journal-title":"Cureus"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-204163"},{"issue":"3","key":"e_1_3_4_10_2","first-page":"136","article-title":"Extreme paralysis following rocuronium administration in a myasthenia gravis patient: a case report","volume":"7","author":"Billups K","year":"2023","unstructured":"Billups K, Collins C, Weber A. Extreme paralysis following rocuronium administration in a myasthenia gravis patient: a case report. Clin Pract Cases Emerg Med 2023; 7(3): 136\u2013139.","journal-title":"Clin Pract Cases Emerg Med"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070671"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08631-5"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1051624"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2000.00042.x"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00265"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.09.015"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27064"},{"issue":"4","key":"e_1_3_4_18_2","article-title":"Association between myasthenia gravis and systemic lupus erythematosus as a comorbid state","volume":"13","author":"Ali M","year":"2021","unstructured":"Ali M, Riad M, Adhikari P, et al. Association between myasthenia gravis and systemic lupus erythematosus as a comorbid state. Cureus 2021; 13(4): e14719.","journal-title":"Cureus"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2020.06.010"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02727-0"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10891-1"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22078-3"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-023-00340-2"},{"issue":"9","key":"e_1_3_4_24_2","article-title":"Relationship between depression and medication adherence among chronic disease patients in the Middle East","volume":"16","author":"Alomar AO","year":"2024","unstructured":"Alomar AO, Khushaim RH, Al-Ghanem SK, et al. Relationship between depression and medication adherence among chronic disease patients in the Middle East. Cureus 2024; 16(9): e69418.","journal-title":"Cureus"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.01.037"},{"key":"e_1_3_4_26_2","first-page":"8967818","article-title":"Comorbid depressive and anxiety symptoms in a patient with myasthenia gravis","volume":"2020","author":"Cherukupally KR","year":"2020","unstructured":"Cherukupally KR, Kodjo K, Ogunsakin O, et al. Comorbid depressive and anxiety symptoms in a patient with myasthenia gravis. Case Rep Psychiatry 2020; 2020: 8967818.","journal-title":"Case Rep Psychiatry"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2015.05.007"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.150205"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/00368504221135469"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-1170-2"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-088813"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01549-z"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.181542"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26104"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2020.1807577"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.04.002"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.54029\/2022tej"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2017.1344237"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03406-0"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.4103\/neurol-india.NI_562_17"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27331"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.16"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.7.1487"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198703193161205"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25198"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-29"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318258f744"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)90099-X"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2023.04.004"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v11.i8.412"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-019-01213-7"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.102266"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1223322"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07368-0"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.02.009"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00478"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040909"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2015.1030614"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117549"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_452_17"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116648"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.09.002"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.886625"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.553626"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251344742","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864251344742","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251344742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:05:42Z","timestamp":1767675942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864251344742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":67,"alternative-id":["10.1177\/17562864251344742"],"URL":"https:\/\/doi.org\/10.1177\/17562864251344742","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"article-number":"17562864251344742"}}